Subsidiary of Zhejiang Orient Gene Biotech (688298.SH) obtains medical device registration certificate.
Dongfang Biology (688298.SH) has issued an announcement, stating that its subsidiary Shanghai Huizijian Biological Technology Co., Ltd. and He...
Zhejiang Orient Gene Biotech (688298.SH) has announced that its subsidiary, Shanghai Wanzijian Biotechnology Co., Ltd. and Healgen Scientific LLC (referred to as "American Healgen"), have obtained medical device registration certificates for multiple products in China, Australia, and Singapore recently.
The above-mentioned registered products have enriched the company's flow cytometry technology platform product range. The respiratory tract three-in-one test product has expanded the international market for sale, which is beneficial for the overall expansion of related products in domestic and foreign markets.
 Related Articles 

As of the end of October, Midea Group Co., Ltd (000333.SZ) has cumulatively used repurchase funds amounting to 9.575 billion yuan.

On November 4th, IVD MEDICAL (01931) spent 10.31 million Hong Kong dollars to repurchase 1.823 million shares.

TWINTEK (06182) changes ownership, receives a discount of approximately 74.3% for the complete takeover offer, and is scheduled to resume trading on November 5th.
As of the end of October, Midea Group Co., Ltd (000333.SZ) has cumulatively used repurchase funds amounting to 9.575 billion yuan.

On November 4th, IVD MEDICAL (01931) spent 10.31 million Hong Kong dollars to repurchase 1.823 million shares.

TWINTEK (06182) changes ownership, receives a discount of approximately 74.3% for the complete takeover offer, and is scheduled to resume trading on November 5th.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


